PMC:7243768 / 30384-30547 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T273","span":{"begin":58,"end":64},"obj":"Body_part"}],"attributes":[{"id":"A273","pred":"fma_id","subj":"T273","obj":"http://purl.org/sig/ont/fma/fma9637"}],"text":"vasoconstriction and vascular permeability which leads to tissue injury [89] (represented in Table 1).\nTherefore, the use of ACEi, ARBs, and mineralocorticoids has"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T132","span":{"begin":58,"end":64},"obj":"Body_part"}],"attributes":[{"id":"A132","pred":"uberon_id","subj":"T132","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"vasoconstriction and vascular permeability which leads to tissue injury [89] (represented in Table 1).\nTherefore, the use of ACEi, ARBs, and mineralocorticoids has"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T350","span":{"begin":65,"end":71},"obj":"Disease"}],"attributes":[{"id":"A350","pred":"mondo_id","subj":"T350","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"}],"text":"vasoconstriction and vascular permeability which leads to tissue injury [89] (represented in Table 1).\nTherefore, the use of ACEi, ARBs, and mineralocorticoids has"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T416","span":{"begin":160,"end":163},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"vasoconstriction and vascular permeability which leads to tissue injury [89] (represented in Table 1).\nTherefore, the use of ACEi, ARBs, and mineralocorticoids has"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T170","span":{"begin":125,"end":129},"obj":"Chemical"},{"id":"T171","span":{"begin":141,"end":159},"obj":"Chemical"}],"attributes":[{"id":"A170","pred":"chebi_id","subj":"T170","obj":"http://purl.obolibrary.org/obo/CHEBI_35457"},{"id":"A171","pred":"chebi_id","subj":"T171","obj":"http://purl.obolibrary.org/obo/CHEBI_25354"}],"text":"vasoconstriction and vascular permeability which leads to tissue injury [89] (represented in Table 1).\nTherefore, the use of ACEi, ARBs, and mineralocorticoids has"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T52","span":{"begin":0,"end":16},"obj":"http://purl.obolibrary.org/obo/GO_0042310"}],"text":"vasoconstriction and vascular permeability which leads to tissue injury [89] (represented in Table 1).\nTherefore, the use of ACEi, ARBs, and mineralocorticoids has"}